1
|
Shcharbin D, Zhogla V, Abashkin V, Gao Y, Majoral JP, Mignani S, Shen M, Bryszewska M, Shi X. Recent advances in multifunctional dendrimer-based complexes for cancer treatment. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY 2024; 16:e1951. [PMID: 38456205 DOI: 10.1002/wnan.1951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Revised: 01/29/2024] [Accepted: 02/20/2024] [Indexed: 03/09/2024]
Abstract
The application of nanotechnology in biological and medical fields have resulted in the creation of new devices, supramolecular systems, structures, complexes, and composites. Dendrimers are relatively new nanotechnological polymers with unique features; they are globular in shape, with a topological structure formed by monomeric subunit branches diverging to the sides from the central nucleus. This review analyzes the main features of dendrimers and their applications in biology and medicine regarding cancer treatment. Dendrimers have applications that include drug and gene carriers, antioxidant agents, imaging agents, and adjuvants, but importantly, dendrimers can create complex nanosized constructions that combine features such as drug/gene carriers and imaging agents. Dendrimer-based nanosystems include different metals that enhance oxidative stress, polyethylene glycol to provide biosafety, an imaging agent (a fluorescent, radioactive, magnetic resonance imaging probe), a drug or/and nucleic acid that provides a single or dual action on cells or tissues. One of major benefit of dendrimers is their easy release from the body (in contrast to metal nanoparticles, fullerenes, and carbon nanotubes), allowing the creation of biosafe constructions. Some dendrimers are already clinically approved and are being used as drugs, but many nanocomplexes are currently being studied for clinical practice. In summary, dendrimers are very useful tool in the creation of complex nanoconstructions for personalized nanomedicine. This article is categorized under: Diagnostic Tools > Diagnostic Nanodevices Diagnostic Tools > In Vivo Nanodiagnostics and Imaging Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.
Collapse
Affiliation(s)
- Dzmitry Shcharbin
- Institute of Biophysics and Cell Engineering of NASB, Minsk, Belarus
| | - Viktoria Zhogla
- Institute of Biophysics and Cell Engineering of NASB, Minsk, Belarus
| | - Viktar Abashkin
- Institute of Biophysics and Cell Engineering of NASB, Minsk, Belarus
| | - Yue Gao
- State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai, China
| | - Jean-Pierre Majoral
- Laboratoire de Chimie de Coordination du CNRS, Toulouse, France
- Université Toulouse, Toulouse, France
| | - Serge Mignani
- Centro de Química da Madeira (CQM), MMRG, Universidade da Madeira, Campus Universitário da Penteada, Funchal, Portugal
| | - Mingwu Shen
- State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai, China
| | - Maria Bryszewska
- Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland
| | - Xiangyang Shi
- State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai, China
- Centro de Química da Madeira (CQM), MMRG, Universidade da Madeira, Campus Universitário da Penteada, Funchal, Portugal
| |
Collapse
|
2
|
Panza G, Montanari M, Lopez D, Burattini S, Ciacci C, Fumelli PP, Pasini G, Fusi V, Giorgi L, Grandoni F, Papa S, Santolini R, Canonico B. Flow cytometric analysis of hepatopancreatic cells from Armadillidium vulgare highlights terrestrial isopods as efficient environmental bioindicators in ex vivo settings. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2024; 31:9745-9763. [PMID: 38194171 PMCID: PMC10824867 DOI: 10.1007/s11356-023-31375-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Accepted: 12/01/2023] [Indexed: 01/10/2024]
Abstract
Several studies have reported the high bioindication capacity of Isopoda (Crustacea, Oniscidea), which is related to their important ability to accumulate contaminants, usefulness in soil ecotoxicology and bioindication activities. Any change in the isopod population, diversity and life cycle can indicate relevant pollution levels. The analysis of target tissues, such as the hepatopancreas, is another emerging approach (from a cytologic/histological level) to detect contaminant accumulation from different sources. In this study, tissue disaggregation procedures were optimised in the hepatopancreas, and flow cytometry (FC) was applied to detect cell viability and several cell functions. After disaggregation, two hepatopancreatic cell types, small (S) and big (B), were still recognisable: they differed in morphology and behaviour. The analyses were conducted for the first time on isopods from sites under different conditions of ecological disturbance through cytometric re-interpretation of ecological-environmental parameters. Significant differences in cell functional parameters were found, highlighting that isopod hepatopancreatic cells can be efficiently analysed by FC and represent standardisable, early biological indicators, tracing environmental-induced stress through cytologic/histologic analyses.
Collapse
Affiliation(s)
- Giovanna Panza
- Department of Biomolecular Sciences (DISB), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Mariele Montanari
- Department of Biomolecular Sciences (DISB), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Daniele Lopez
- Department of Biomolecular Sciences (DISB), University of Urbino Carlo Bo, 61029, Urbino, Italy
- Department of Pure and Applied Sciences (DiSPeA), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Sabrina Burattini
- Department of Biomolecular Sciences (DISB), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Caterina Ciacci
- Department of Biomolecular Sciences (DISB), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Piermarco Paci Fumelli
- Department of Biomolecular Sciences (DISB), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Giovanni Pasini
- Centro Ricerche Ecologiche E Naturalistiche (CREN), Soc. Coop., 47922, Rimini, Italy
| | - Vieri Fusi
- Department of Pure and Applied Sciences (DiSPeA), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Luca Giorgi
- Department of Pure and Applied Sciences (DiSPeA), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Francesco Grandoni
- Centro Di Ricerca Zootecnia E Acquacoltura (Research Centre for Animal Production and Aquaculture), CREA - Consiglio per la Ricerca in Agricoltura e l'Analisi dell'Economia Agraria, Monterotondo, Rome, Italy
| | - Stefano Papa
- Department of Biomolecular Sciences (DISB), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Riccardo Santolini
- Department of Humanistic Studies (DISTUM), University of Urbino Carlo Bo, 61029, Urbino, Italy
| | - Barbara Canonico
- Department of Biomolecular Sciences (DISB), University of Urbino Carlo Bo, 61029, Urbino, Italy.
| |
Collapse
|
3
|
Pricl S. The Spicy Science of Dendrimers in the Realm of Cancer Nanomedicine: A Report from the COST Action CA17140 Nano2Clinic. Pharmaceutics 2023; 15:2013. [PMID: 37514199 PMCID: PMC10384593 DOI: 10.3390/pharmaceutics15072013] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Revised: 07/12/2023] [Accepted: 07/13/2023] [Indexed: 07/30/2023] Open
Abstract
COST Action CA17140 Cancer Nanomedicine-from the bench to the bedside (Nano2Clinic,) is the first, pan-European interdisciplinary network of representatives from academic institutions and small and medium enterprises including clinical research organizations (CROs) devoted to the development of nanosystems carrying anticancer drugs from their initial design, preclinical testing of efficacy, pharmacokinetics and toxicity to the preparation of detailed protocols needed for the first phase of their clinical studies. By promoting scientific exchanges, technological implementation, and innovative solutions, the action aims at providing a timely instrument to rationalize and focus research efforts at the European level in dealing with the grand challenge of nanomedicine translation in cancer, one of the major and societal-burdening human pathologies. Within CA17140, dendrimers in all their forms (from covalent to self-assembling dendrons) play a vital role as powerful nanotheranostic agents in oncology; therefore, the purpose of this review work is to gather and summarize the major results in the field stemming from collaborative efforts in the framework of the European Nano2Clinic COST Action.
Collapse
Affiliation(s)
- Sabrina Pricl
- Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), Department of Engineering and Architecture (DEA), University of Trieste, Piazzale Europa 1, 34127 Trieste, Italy
- Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, ul. Pomorska 141/143, 90-236 Lodz, Poland
| |
Collapse
|
4
|
Said AI, Staneva D, Grabchev I. New Water-Soluble Poly(propylene imine) Dendrimer Modified with 4-Sulfo-1,8-naphthalimide Units: Sensing Properties and Logic Gates Mimicking. SENSORS (BASEL, SWITZERLAND) 2023; 23:s23115268. [PMID: 37299994 DOI: 10.3390/s23115268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 05/28/2023] [Accepted: 05/30/2023] [Indexed: 06/12/2023]
Abstract
A new water-soluble poly(propylene imine) dendrimer (PPI) modified with 4-sulfo-1,8-naphthalimid units (SNID) and its related structure monomer analog (SNIM) has been prepared by a simple synthesis. The aqueous solution of the monomer exhibited aggregation-induced emission (AIE) at 395 nm, while the dendrimer emitted at 470 nm due to an excimer formation beside the AIE at 395 nm. Fluorescence emission of the aqueous solution of either SNIM or SNID was significantly affected by traces of different miscible organic solvents, and the limits of detection were found to be less than 0.05% (v/v). Moreover, SNID exhibited the function to execute molecular size-based logic gates where it mimics XNOR and INHIBIT logic gates using water and ethanol as inputs and the AIE/excimer emissions as outputs. Hence, the concomitant execution of both XNOR and INHIBIT enables SNID to mimic digital comparators.
Collapse
Affiliation(s)
- Awad I Said
- Faculty of Medicine, Sofia University "St. Kliment Ohridski", 1407 Sofia, Bulgaria
- Department of Chemistry, Faculty of Science, Assiut University, Assiut 71516, Egypt
| | - Desislava Staneva
- Department of Textile, Leader, and Fuels, University of Chemical Technology and Metallurgy, 1756 Sofia, Bulgaria
| | - Ivo Grabchev
- Faculty of Medicine, Sofia University "St. Kliment Ohridski", 1407 Sofia, Bulgaria
| |
Collapse
|
5
|
Staneva D, Manov H, Vasileva‐Tonkova E, Kukeva R, Stoyanova R, Grabchev I. Enhancing the antibacterial activity of
PAMAM
dendrimer modified with 1,8‐naphthalimides and its copper complex via light illumination. POLYM ADVAN TECHNOL 2022. [DOI: 10.1002/pat.5768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Desislava Staneva
- Department of Textile, Leader and Fuels University of Chemical Technology and Metallurgy Sofia Bulgaria
| | - Hristo Manov
- Faculty of Chemistry and Pharmacy Sofia University “St. Kliment Ohridski” Sofia Bulgaria
| | | | - Rositsa Kukeva
- Institute of General and Inorganic Chemistry Bulgarian Academy of Sciences Sofia Bulgaria
| | - Radostina Stoyanova
- Institute of General and Inorganic Chemistry Bulgarian Academy of Sciences Sofia Bulgaria
| | - Ivo Grabchev
- Faculty of Medicine Sofia University “St. Kliment Ohridski” Sofia Bulgaria
| |
Collapse
|